Department of Physiology and Biophysics, Center for Excellence in Cardiovascular Research, The University of Mississippi Medical Center, Jackson, Mississippi, USA.
Curr Opin Nephrol Hypertens. 2013 Mar;22(2):156-62. doi: 10.1097/MNH.0b013e32835d19f7.
Emerging evidence supports an important role for the heme oxygenase system in the maintenance of a healthy pregnancy. This review attempts to collect these wide-ranging data and summarize the recent progress in the field.
New studies looking at heme oxygenase depletion in a variety of animal models have demonstrated that the heme oxygenase system is an important regulator of placental development, particularly in vascular structure. Furthermore, emerging studies demonstrate a role for heme oxygenase in the maintenance of pregnancy, especially during pathological challenge. Intriguingly, it now appears that the heme oxygenase system can be dramatically altered by pathological disorders of pregnancy, in particular preeclampsia, perhaps functionally in the symptomatic phase of the disorder. Promisingly, however, recent data suggest that induction of the heme oxygenase system, or administration of its bioactive metabolites, could provide a promising novel therapeutic approach to the management of this currently untreatable disease.
Long considered a molecular housekeeping system, the heme oxygenase system is now known to be an important stress response pathway. New evidence suggests that it is also an important player in pregnancy and preeclampsia. However, the evidence now also suggests that it may provide a therapeutic approach for this common disease with few management options.
新出现的证据支持血红素加氧酶系统在维持健康妊娠中起着重要作用。本综述试图收集这些广泛的数据,并总结该领域的最新进展。
新的研究观察到各种动物模型中血红素加氧酶的耗竭,表明血红素加氧酶系统是胎盘发育的重要调节剂,特别是在血管结构中。此外,新出现的研究表明血红素加氧酶在妊娠维持中的作用,特别是在病理挑战期间。有趣的是,现在似乎表明,血红素加氧酶系统可以通过妊娠的病理紊乱,特别是子痫前期,显著改变,可能在该疾病的症状阶段具有功能性。然而,有希望的是,最近的数据表明,诱导血红素加氧酶系统或其生物活性代谢物的给药可能为治疗这种目前无法治疗的疾病提供一种有前途的新治疗方法。
血红素加氧酶系统长期以来被认为是一种分子管家系统,现在已知是一种重要的应激反应途径。新的证据表明,它也是妊娠和子痫前期的重要参与者。然而,现在的证据也表明,它可能为这种治疗选择有限的常见疾病提供一种治疗方法。